(1) Haridas A, Kushon D, Gurmu S, Oluwabusi O. Smoking Quetiapine: A “Maq Ball”? Primary Psychiatry 2010; 17(9):38-39
[accessible en: http://www.primarypsychiatry.com/aspx/articledetail.aspx?articleid=2826].
(2) Bogart GT, Ott CA. Abuse of second-generation antipsychotics: What prescribers need to know. Current Psychiatry 2011; 10
(5): 77-9 [Accesible...
(3) Kales HC, Zivin K, Kim HM, Valenstein M, Chiang C, Ignacio R, et al. Trends in antipsychotic use in dementia 1999-2007. Arch
Gen Psychiatry...
(4) Kales HC, Valenstein M, Kim HM, McCarthy JF, Ganoczy D, Cunningham F, et al. Mortality risk in patients with dementia treated with antipsychotics...
(5) Levinson DR. Medicare atypical antipsychotic drug claims for elderly nursing home residents. Department of Health and Human Services....
(6) Moran M. Misuse of Antipsychotics Widespread in Nursing Homes. Psychiatric News 2011; 46 (11): 2 [Accesible en: http://
pn.psychiatryonline.org/content/46/11/2.2.full].
(7) Food and Drug Administration. Antipsychotic drugs: Class Labeling Change - Treatment During Pregnancy and Potential Risk
to Newborns;...
(8) Sinclair L. Antipsychotic Labels to Cite Risks to Newborns. Psychiatric News 2011; 46 (7): 12 [Accesible en: http://
pn.psychiatryonline.org/content/46/7/12.1.full].
(9) Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode...
(10) Boonstra G, van Haren NE, Schnack HG, Cahn W, Burger H, Boersma M, et al. Brain volume changes after withdrawal of atypical antipsychotics...
(11) Nielsen J, Damkier P, Lublin H, Taylor D. Optimizing clozapine treatment. Acta Psychiatr Scand 2011; 123: 411-22 [Abstract: http://www.ncbi.nlm.nih.gov/pubmed/10372609].
(12) Anónimo. Clozapine and severe constipation. Medicines Safety Update 2011; 2(1) [Accesible en: http://www.australianprescriber.com/magazine/34/1/22/5].
(13) Subotnik KL, Nuechterlein KH, Ventura J, Gitlin MJ, Marder S, Mintz J, et al. Risperidone nonadherence and return of positive symptoms...
(14) Rosenheck RA, Krystal JH, Lew R, Barnett PG, Fiore L, Valley D, et al. Long-acting risperidone and oral antipsychotics in unstable schizophrenia....
(15) Tiihonen J, Haukka J, Taylor M, Haddad PM, Patel MX, Korhonen P. A nationwide cohort study of oral and depot antipsychotics after first...
(16) Taylor D. Antipsychotic polypharmacy - confusion reigns. The Psychiatrist 2010; 34: 41-43 [Accesible en: http://pb.rcpsych.org/cgi/content/full/34/2/41].
(17) Kinon BJ, Potts AJ, Watson SB. Placebo Response in Clinical Trials with Schizophrenia Patients. Curr Opin Psychiatry 2011;
24: 107-13...
(18) Lepping P, Sambhi RS, Whittington R, Lane S, Poole R. Clinical relevance of findings in trials of antipsychotics: systematic
review....
(19) Van Soolingen D, HernandezPando R, Orozco H, Aguilar D, Magis-Escurra C, Amaral L, et al. The antipsychotic thioridazine shows promising...
(20) Young AH. More good news about the magic ion: lithium may prevent dementia. Br J Psychiatry 2011; 198: 336-7 [Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21525515].
(21) Kapusta ND, Mossaheb N, Etzersdorfer E, Hlavin G, Thau K, Willeit M, et al. Lithium in drinking water and suicide
mortality. Br J Psychiatry...
(22) Kabacs N, Memon A, Obinwa T, Stochl J, Perez J.Lithium in drinking water and suicide rates across the East of England. Br J Psychiatry...
(23) Food and Drug Administration. Suicidal Behavior and Ideation and Antiepileptic Drugs; 5/5/2009 [Accesible en: http://
www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/UCM100190].
(24) Redden L, Pritchett Y, Robieson W, Kovacs X, Garofalo M, Tracy K, et al. Suicidality and divalproex sodium: analysis of controlled studies...
(25) Fountoulakis KN, Gonda X, Vieta E, Rihmer Z. Class effect of pharmacotherapy in bipolar disorder: fact or misbelief? Ann Gen Psychiatry...
(26) Abilify. Ficha técnica o resumen de las características del producto [Accesible en: http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-_Product_Information/human/000471/WC500020170.pdf].
(27) Tsai AC, Rosenlicht NZ, Jureidini JN, Parry PI, Spielmans GI, Healy D. Aripiprazole in the Maintenance Treatment of Bipolar Disorder:...
(28) Cosgrove L, Shi L, Creasey DE, Anaya-McKivergan M, Myers JA, Huybrechts KF. Antidepressants and breast and ovarian cancer risk: a review...
(29) Wu CS, Wang SC, Cheng YC, Gau SS. Association of cerebrovascular events with antidepressant use: a case-crossover study. Am J Psychiatry...
(30) Porcelli S, Drago A, Fabbri C, Gibiino S, Calati R, Serretti A. Pharmacogenetics of antidepressant response. J Psychiatry Neurosci 2011;...
(31) Warner-Schmidt JL, Vanover KE, Chen EY, Marshall JJ, Greengard P. From the Cover: Antidepressant effects of selective
serotonin reuptake...
(32) Moran M. Viibryd approved for treatment of major depression. Psychiatric News 2011; 46 (5): 6 [Accesible en: http://
pn.psychiatryonline.org/content/46/5/6.2.full].
(33) Wimbiscus M, Kostenko O, Malone D. MAO inhibitors: risks, benefits, and lore. Cleve Clin J Med. 2010; 77): 859-82 [Accesible en: http://www.ccjm.org/content/77/12/859.long].
(34) el-Guebaly N, Sareen J, Stein MB. Are there guidelines for the responsible prescription of benzodiazepines? Can J Psychiatry 2010; 55:...
(35) Casher MI, Gih D, Bess JD. Benzodiazepines and stimulants for patients with substance use disorders. Current Psychiatry
2001; 10 (5):...
(36) Kern Pharma SL. Distraneurine, nº Reg 46.186. Comunicación de Desabastecimiento (carta), 23 de marzo de 2011 [Accesible en: http://www.kernpharma.com/wp-content/uploads/2011/03/Distaneurine1.pdf].
(37) Inagaki T, Miyaoka T, Tsuji S, Inami Y, Nishida A, Horiguchi J. Adverse reactions to zolpidem: case reports and a review of the literature....
(38) Scher LM, Loomis E, McCarron RM. Traumatic brain injury: pharmacotherapy options for cognitive deficits. Current Psychiatry 2011; 10(2):...
(39) Rifai MA, Gleason OC, Sabouni D. Psychiatric care of the patient with hepatitis C: a review of the literature. Prim Care Companion J...
(40) Sarwer DB, Falcounbridge LF, Steffen KJ, Roerig JL, Mitchell JE. Bariatric procedures: managing patients after surgery. Current Psychiatry...
(41) Moses GM, McGuire TM. Drug interactions with complementary medicines. Aust Prescr 2010; 33: 177-80 [Accesible en: http://www.australianprescriber.com/magazine/33/6/177/80].
(42) Moore TJ, Glenmullen J, Furberg CD. Prescription drugs associated with reports of violence towards others. PLoS One 2010; 5(12): e15337...
(43) Van Ommeren M, Barbui C, de Jong K, Dua T, Jones L, Perez-Sales P, et al. If You Could Only Choose Five Psychotropic Medicines: Updating...
(44) Geier DA, Geier MR. A Clinical and Laboratory Evaluation of Methionine CycleTranssulfuration and Androgen Pathway Markers in Children...
(45) Sansone RA, Sansone LA. Getting a knack for NAC: N-Acetyl-Cysteine. Innov Clin Neurosci 2011; 8: 10-14 [Accesible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3036554/pdf/icns_8_1_10.pdf].
(46) Dean O, Giorlando F, Berk M. Nacetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action. J Psychiatry...